SAN FRANCISCO — Lawsuits are continuing to pile up against Theranos Inc., the once vaunted Silicon Valley medical startup, in the wake of the company’s May disclosure that it had been forced to void thousands of blood tests because the results were unreliable.
On Tuesday, attorneys at Kaplan Fox & Kilsheimer joined the fray, filing a proposed class action in the U.S. District Court for the Northern District of California on behalf of all consumers who purchased a Theranos lab test back to 2013. The suit throws breach of contract claims at Theranos and alleges violations of California false advertising and unfair competition laws.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
